RALEIGH, N.C. & NEW YORK--(BUSINESS WIRE)--INC Research Holdings, Inc. (NASDAQ:INCR), a leading, global Phase I to IV contract research organization (CRO), and Medidata (NASDAQ:MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, today announced that INC Research has been named the recipient of Medidata’s Trial of the Future Award in the Operational Excellence category.
“The Medidata Trial of the Future Award is a strong testament to INC’s ability to leverage the latest technologies to help our customers develop new medicines as quickly, efficiently and safely as possible,” said Jamie Macdonald, Chief Executive Officer, INC Research. “Our longstanding relationship with Medidata and the use of its Clinical Cloud platform is one of the ways INC stays at the forefront of operational excellence in providing our customers with access to the data they need to accomplish their clinical development goals.”
Presented to INC Research during the Medidata Symposium on October 6, 2015—at the National Portrait Gallery in Washington, DC—the award celebrates excellence in advancing drug development and the delivery of innovative new therapies to market. In its inaugural year, the Trial of the Future Awards honor life sciences companies excelling in four categories: Innovation, Operational Excellence, Technology and Collaboration.
INC Research was recognized for its efficient use and adoption of leading-edge technology and analytics within Medidata’s integrated cloud solution for electronic data capture (Medidata Rave®) and operational clinical trial management (Medidata CTMS™), bringing immediate benefits to its pharmaceutical and biotechnology customers.
Steve Hirschfeld, Medidata’s Chief Commercial Officer, added: “INC Research is a true industry trailblazer—a leader in embracing change and new processes. The INC team is very deserving of this award, with their drive to increase efficiencies by quickly adopting new methods and technologies into their clinical development processes. We’re excited to see our partnership grow as INC continues to leverage our ever-evolving cloud platform to further enhance its innovative, high-quality research services—ultimately helping its customers bring new therapies to patients around the world.”
Connect with Medidata
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata honors @INC_Research w/ inaugural Trial of the Future Award in Operational #Excellence. http://ow.ly/T6l2B #clinicaltrials
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com.
Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud® brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.